OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ANAB

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

AnaptysBio (ANAB) Earnings Date & Reports

AnaptysBio Inc is a clinical-stage biotechnology company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ANAB is expected to report earnings to rise 17.16% to -157 cents per share on November 11

Q3'25

Est.

$-1.57

Q2'25

Beat

by $0.18

Q1'25

Beat

by $0.02

Q4'24

Beat

by $0.90

Q3'24

Beat

by $0.56

The last earnings report on August 07 showed earnings per share of -134 cents, beating the estimate of -151 cents. With 1.05M shares outstanding, the current market capitalization sits at 588.27M.

View a ticker or compare two or three

Compare

ANAB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ANAB
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ANAB showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a provider of therapeutic antibodies for inflammation and immuno-oncology

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

10770 Wateridge Circle

Phone

+1 858 362-6295

Employees

117

Web

https://www.anaptysbio.com